This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Chronic and advanced schistosomiasis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

chronic and advanced disease

Chronic and advanced disease is caused by mature, patent, schistosome infections (1).

Eggs which are not excreted usually become permanently lodged in the intestines or liver (for S mansoni, S japonicum, and S mekongi) or in the bladder and urogenital system (for S haematobium)

  • these eggs cause a granulomatous host immune response which in turn induces chronic inflammation that leads to the disease manifestations of schistosomiasis (1,2)

Parasites require to expel its ova to the external environment for species survival, hence the worms lay their eggs as near as possible to the exterior environment:

  • in the urinary bladder - Schistosoma haematobium
  • in the distal colon and rectum - Schistosoma mansoni, S. japonicum, Schistosoma intercalatum and Schistosoma mekongi

These sites are considered as "primary targets" while lesions may spell over into "secondary targets" by different mechanisms e.g. - upper urinary tract may be involved as a result of obstruction or reflux at the uretero-vesical junctions (2).

Reference:

  • (1) Gray DJ et al. Diagnosis and management of schistosomiasis. BMJ. 2011;342:d2651.
  • (2) Barsoum RS, Esmat G, El-Baz T. Human schistosomiasis: clinical perspective: review. J Adv Res. 2013;4(5):433-44.

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.